Abstract:Physical attractiveness, despite sustained exhortations that beauty is only skin deep and that one should not judge the book by its cover, significantly impacts practically every aspect of interpersonal relationships. Physically attractive women are admired and handsomely paid to be models, glamorized as movie actresses, and blamed for being greatly responsible for widespread body dissatisfaction and eating disorders in young women. The argument that fairy tales and the media link physical beauty to positive attributes does not explain why children as young as 14 hours old gaze at adults judged to have attractive female faces longer than those who have unattractive faces. What is the basis for such allure and power of attractiveness? To understand the nature of physical attractiveness, the first step is to identify features that a majority of people find attractive and to search for a basis of consensus. Evolutionary psychologists use such an approach. Simply stated, evolutionary theorists argue that physical attractiveness reliably conveys biological information about a person's genetic quality, health, and reproductive potential. Being able to judge these attributes reliably would have enabled people in Stone Age environments to select healthy mates and be reproductively successful, as healthy mates would be better providers and protractors for the family unit. The problem is that the reproductive potential, capability, and genetic resistance to disease cannot be directly observed. Therefore, the selection process has shaped mental mechanisms to attend to those bodily features that are reliable indicators of health and fertility, and such features are judged to be desirable and attractive. Although people are not consciously aware of such a link, therein lies the power of physical attractiveness. Many evolution-inspired researchers have started to explore whether the facial features that are judged to be attractive, such as full lips, small chin, symmetry of bilateral facial features, and so forth, are indicators of sex hormone, reproductive potential, and healthiness (e.g., Johnston, Hagel, Franklin, Fink, & Grammer, 2001). Physical attractiveness depends on both facial and bodily features, but strangely, all the detailed analysis of what constitutes attractiveness and its link to genetic quality is restricted to faces. The attractiveness of the body, in spite of clear age-related change (e.g., prepubertal, postpubertal, and menopausal) is solely defined by body weight; skinny women are more

Promoter Hypermethylation of the Reck Gene is Associated with Its Low Expression and Poor Survival of Esophageal Squamous Cell Carcinoma

Low Expression of RECK in Oral Squamous Cell Carcinoma Patients Induces a Shorter Survival Rate Through an Imbalance of RECK/MMPs.

Dysregulation of CXCL14 promotes malignant phenotypes of esophageal squamous carcinoma cells via regulating SRC and EGFR signaling

The clinicopathological significance of HES1 promoter hypomethylation in patients with colorectal cancer.

Hypermethylation Status of RASSF1A Gene Promoter Region in Esophageal Squamous Cell Carcinoma

Analysis of RUNX3 promoter hypermethylation in serum DNA of esophageal squamous cell carcinoma patients

RECK expression is associated with angiogenesis and immunogenic Tumor Microenvironment in Hepatocellular Carcinoma, and is a prognostic factor for better survival

Correlation of RASSF1A and MINT31 Promoter Hypermethylation with Esophageal Intraepithelial Neoplasia and Esophageal Squamous Cell Carcinoma

Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma

76 WHOLE-EXOME SEQUENCING EXPLORES DIFFERENTIAL GENES EXPRESSION OF METASTASIS IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A PROPENSITY-SCORE MATCHING STUDY

Expression of ECRG4, a Novel Esophageal Cancer-Related Gene, Downregulated by CpG Island Hypermethylation in Human Esophageal Squamous Cell Carcinoma

Promoter methylation and its significance of hMLH1, E-cadherin and p16INK4a gone in esophageal squamous cell carcinoma

Secretoglobin-3A1 Gene Promoter Hypermethylation Relevant to Esophageal Squamous Cell Carcinoma

Combined intramuscular oxytetracycline and oral tiamulin treatment of sheep in the elimination of urogenital ureaplasmas.

Epigenetic Silencing of RASSF10 Promotes Tumor Growth in Esophageal Squamous Cell Carcinoma.

19q13 KRAB zinc-finger protein ZNF471 activates MAPK10/JNK3 signaling but is frequently silenced by promoter CpG methylation in esophageal cancer

An Evolutionary Theory of Female Physical Attractiveness

Cpg Island Methylation Status Of Mirnas In Esophageal Squamous Cell Carcinoma

Aberrant Methylation of the TERT Promoter in Esophageal Squamous Cell Carcinoma.

High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy

Targeted demethylation at ZNF154 promotor upregulates ZNF154 expression and inhibits the proliferation and migration of Esophageal Squamous Carcinoma cells